Non-invasive method of propelling high concentrations medication
Iontophoresis is a non-invasive method of propelling high concentrations of a medication transdermally by use of a small electrical charge (an injection without a needle). This method of drug delivery is commonly used to treat site-specific inflammatory and other musculoskeletal conditions and is typically administered in a series of treatments by a healthcare provider within the clinic. The product line consists of both a self-contained patch, similar to a large band aid, as well as the more traditional clinical dose controller to drive the current through the disposable delivery electrodes. The Iontophoresis market is well established, has existed over several decades and primarily allows clinics to get paid by health insurance as they treat their patients.
Zynex's ceo, Thomas Sandgaard, commented, "We are very excited about http://bit.ly/rCnFks